Ashoke Khanwalkar, MD

I am a sinus specialist trained in the management of patients with HHT epistaxis. While completing a fellowship at Stanford, I published a randomized controlled clinical trial investigating the benefit of local submucosal injection of bevacizumab (Avastin) at the time of bipolar electrocautery in the OR, and demonstrated an improvement in intensity, frequency, and duration of epistaxis up to 6 months after surgery. I appreciate the opportunity to take care of this patient population.